This post was written by Erin Janssen.

FDA will conduct a 2-day public hearing on April 23 and 24, 2012 to obtain input from interested persons on FDA’s scope and direction in modernizing the regulations, policies, and practices that apply to the conduct of clinical trials of FDA-regulated products. Individuals who wish to attend or present at the public hearing must register by April 2, 2012.